- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 241/16 - Halogen atomsNitro radicals
Patent holdings for IPC class C07D 241/16
Total number of patents in this class: 58
10-year publication summary
|
7
|
4
|
8
|
2
|
7
|
2
|
4
|
1
|
5
|
1
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Sumitomo Chemical Company, Limited | 9031 |
10 |
| Nippon Soda Co., Ltd. | 894 |
3 |
| Novartis AG | 10886 |
2 |
| LG Chem, Ltd. | 17594 |
2 |
| Boehringer Ingelheim International GmbH | 4697 |
2 |
| Syngenta Participations AG | 1907 |
2 |
| Centre National de La Recherche Scientifique | 10408 |
2 |
| Commissariat à l'énergie atomique et aux energies alternatives | 10922 |
2 |
| Institut Pasteur | 786 |
2 |
| Nihon Nohyaku Co., Ltd. | 325 |
2 |
| The Scripps Research Institute | 1347 |
2 |
| Teva Pharmaceutical Industries Ltd. | 796 |
2 |
| The United States of America as represented by the Department of Veterans Affairs | 302 |
2 |
| University of Pittsburgh - Of the Commonwealth System of Higher Education | 3137 |
2 |
| Bristol-myers Squibb Company | 4879 |
1 |
| BASF SE | 20892 |
1 |
| The Regents of the University of California | 19857 |
1 |
| Merck Sharp & Dohme Corp. | 2200 |
1 |
| AstraZeneca AB | 2928 |
1 |
| Merck Patent GmbH | 5873 |
1 |
| Other owners | 15 |